Neuraptive Therapeutics begins patient enrollment in NTX-001 facial paralysis trial
Neuraptive Therapeutics said that it has enrolled the first patient in its phase 2a clinical trial of NTX-001 for the treatment and prevention of facial paralysis needing surgical repair. The mid-stage facial paralysis prevention study will assess the safety and efficacy of NTX-001 in peripheral nerve injuries caused by trauma in comparison to the standard […]